Herzuma (trastuzumab)

pCPA File Number: 21130

Negotiation Status:

Concluded with an LOI

Indication(s):

Early breast cancer, Metastatic breast cancer, Metastatic gastric cancer

Sponsor/Manufacturer:

Teva Canada Ltd.

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2019-05-31

Negotiation Process Concluded:

2019-11-13